Discovery of new benzothiazole-1,2,3-triazole hybrid-based hydrazone/thiosemicarbazone derivatives as potent EGFR inhibitors with cytotoxicity against cancer
RSC Advances · 2025 · 15 (5) · 3570-3591
DOI: 10.1039/d4ra07540d ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2025. Verfasst von Ateyatallah Aljuhani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, College of Sciences, Taibah University Al-Madinah Al-Munawarah 41477 Saudi Arabia ateyatallah@hotmail.com mosa_alsehli@hotmail.…. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
New benzothiazole-1,2,3-triazole hybrids-based hydrazone/thiosemicarbazone derivatives exhibited potent EGFR inhibitors with cytotoxicity against breast cancer.
Autor:innen und Institutionen
- Chemistry Department, College of Sciences, Taibah University Al-Madinah Al-Munawarah 41477 Saudi Arabia ateyatallah@hotmail.com mosa_alsehli@hotmail.com Sqahtani@taibahu.edu.sa aouadmohamedreda@yahoo.fr nadjetrezki@yaho…
- Department of Chemistry, College of Sciences, University of Sharjah P.O. 27272 Sharjah United Arab Emirates mohamed.elsayed@sharjah.ac.ae.
- Chemistry Department, Faculty of Science, Suez Canal University P.O. 41522 Ismailia Egypt mohamed_nafie@science.suez.edu.eg.
- Department of Chemistry, School of Science, The University of Jordan Amman 11942 Jordan n.albujuq@ju.edu.jo.
- Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan Amman 11942 Jordan s.bardaweel@ju.edu.jo.
- Medicinal Chemistry Department, Faculty of Pharmacy, Suez Canal University Ismailia 41522 Egypt khaled_darwish@pharm.suez.edu.eg.
ORCID-Profile: Mohamed S Nafie, Nader R Albujuq, Sanaa K Bardaweel, Khaled M Darwish, Mohamed Reda Aouad, Nadjet Rezki
Zitieren
APA
Aljuhani, A., Nafie, M. S., Albujuq, N. R., Alsehli, M., Bardaweel, S. K., Darwish, K. M., Alraqa, S. Y., Aouad, M. R., & Rezki, N. (2025). Discovery of new benzothiazole-1,2,3-triazole hybrid-based hydrazone/thiosemicarbazone derivatives as potent EGFR inhibitors with cytotoxicity against cancer. RSC Advances, 15(5), 3570-3591. https://doi.org/10.1039/d4ra07540d
Vancouver
Aljuhani A, Nafie MS, Albujuq NR, Alsehli M, Bardaweel SK, Darwish KM, et al. Discovery of new benzothiazole-1,2,3-triazole hybrid-based hydrazone/thiosemicarbazone derivatives as potent EGFR inhibitors with cytotoxicity against cancer. RSC Advances. 2025;15(5):3570-3591. doi:10.1039/d4ra07540d
BibTeX
@article{Aljuhani2025,
author = {Aljuhani, Ateyatallah and Nafie, Mohamed S and Albujuq, Nader R and Alsehli, Mosa and Bardaweel, Sanaa K and Darwish, Khaled M and Alraqa, Shaya Y and Aouad, Mohamed Reda and Rezki, Nadjet},
title = {Discovery of new benzothiazole-1,2,3-triazole hybrid-based hydrazone/thiosemicarbazone derivatives as potent EGFR inhibitors with cytotoxicity against cancer},
journal = {RSC Advances},
year = {2025},
volume = {15},
number = {5},
pages = {3570--3591},
doi = {10.1039/d4ra07540d}
}
EUVIMED